Methylene Blue IV

How candidacy for Methylene Blue IV is evaluated

• Medication review is required — methylene blue interacts with serotonergic medications, opioids, and certain antidepressants.
• G6PD deficiency is a contraindication; pregnancy, breastfeeding, and renal considerations are screened.
• Dosing is individualized and physician-guided; informed consent is required.
• Sessions are scheduled only after consultation and screening clear candidacy.
• Results vary; we do not make disease-treatment claims.

Screening, history, and provider guidance determine whether any protocol is appropriate for a given individual. Results vary.

Where this information comes from

Methylene blue has known drug interactions and a G6PD-deficiency contraindication; the IV wellness evidence base outside its FDA-approved indication is limited.

• PROVAYBLUE (methylene blue) — official FDA prescribing label

  DailyMed (U.S. National Library of Medicine)

  Current FDA-approved prescribing information for methylene blue including approved indication, boxed warning, serotonergic drug interactions, and G6PD-deficiency contraindication.

• ASCOR (ascorbic acid injection) — FDA prescribing label

  DailyMed (U.S. National Library of Medicine)

  Current FDA-approved prescribing information for injectable ascorbic acid. Approved indication is short-term treatment of scurvy when oral therapy is unsuitable — not general wellness.

• Intravenous vitamin therapy: much ado about nothing? — DTB review (PMID 37640530)

  Drug and Therapeutics Bulletin / BMJ (PMID 37640530)

  Peer-reviewed review concluding the evidence base for IV vitamin therapy in people without deficiency is weak and does not support routine wellness use.

• Myers' cocktail pilot study (PMID 19250003)

  Journal of Alternative and Complementary Medicine (PMID 19250003)

  Small pilot trial of the Myers' cocktail formulation — hypothesis-generating only, not confirmatory efficacy evidence.

• Intravenous Multivitamin Therapy — evidence review

  NCBI Bookshelf / StatPearls

  Published review of the evidence and guideline context for IV multivitamin infusions. Does not establish efficacy for wellness indications.

• Vitamin C — Health Professional Fact Sheet

  NIH Office of Dietary Supplements

  Authoritative reference on vitamin C physiology and safety context. Does not establish IV vitamin C as a proven wellness intervention.

References describe general evidence, safety, or regulatory context. They do not establish an individual benefit for any specific person, and they do not validate EBO2's proprietary clinic protocols.